6 employees
Levicept develops biological agent for the treatment of chronic pain.
2012
$16M
from 3 investors over 3 rounds
LEVICEPT LTD raised $3.9M on October 8, 2014
Investors: Innovate UK
LEVICEPT LTD raised $16M on October 7, 2014
Investors: Advent Life Sciences and Index Ventures